The CHU de Liège is the coordinator of the ONCOCARE project. It is a large academic hospital strongly experienced in the clinical care of cancer patients. It offers comprehensive diagnostic and therapeutic services to patients and their families. As referral center (over than 2,500 new cancers/year), CHU analyses more than 9,000 pathology specimens, perform more than 8,000 PET scanners, 31,000 chemotherapy preparation and 2,700 radiotherapy treatments every year. With almost 100 transplants/year, it is the second largest hematopoietic cell transplant center in Belgium and the most active internationally. It is the largest and most complete cancer center in the Wallonia Region. Furthermore, it is the only one, structurally connected with a University, mostly through the GIGA Research Institution. Finally, the CHU de Liège has recently created its integrated Cancer Institute to further strengthen its oncological activities. Its Integrated Oncology Center (CIO) dedicated to ambulatory care, is due to open in 2018. The Cancer Institute has set-up an ambitious strategic plan in which many essential items perfectly match the actions developed in OncoCare.
With its recognized expertise in transplantation (HCT), the CHU will be decisive for the JACIE accreditation. He conceptualized the HCT and PROM management tool, finalized the first phase of its clinical trial management tools, and launched a pilot phase of hospitalization at home.